Keith L Knutson

10PUBLICATIONS
56CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 03, 2026
Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.

|Nov 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer.

Keith L Knutson, Hala Abu-Fares, Patricia Keating

|Mar 07, 2025
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer.

Saranya Chumsri, Joseph J Larson, Emily Liu

|May 16, 2024
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.

Daniel P Wickland, Colton McNinch, Erik Jessen

|Apr 15, 2024
Regulation of Tumor Dendritic Cells by Programmed Cell Death 1 Pathways.

Keith L Knutson

|Nov 02, 2023
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade.

Yan Luo, Barath Shreeder, James W Jenkins

Pageof 2

Frequent Collaborators

3 joint publications

E Aubrey Thompson

2 joint publications

Matthew S Block

2 joint publications

Saranya Chumsri

2 joint publications

Yi Liu